Breaking barriers to cure disease

Deep clinical expertise is fundamental to our approach, ensuring that our technologies will work in the clinic. We aim to address critical unmet needs for patients.

Avista’s clinical pipeline

Avista is uniquely positioned at the forefront of innovation, leveraging groundbreaking technologies to create gene therapies for diseases with significant unmet need. Avista is committed to rigorous scientific excellence and patient-focused development, ensuring that the therapies we advance have the potential to deliver real benefit to patients.

Flowchart showing stages in ophthalmology and CNS research, with timelines from discovery through Phase 3, including specific study names and indications.